Is it safe?
Can BIOA take a bad year?
BioAge Labs, Inc. holds $382M more cash than debt, and is burning $22M a quarter, about 4.3 years of cover.
$382M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 24.91
Altman Z-score · safe zone, above 3
- Cash runway
- 4.3 years
Cash runway · burning $22M a quarter at the current rate
Details›
- Total debtQ1 2026
- $1.7M
- Cash and short-term investments
- $383M
- Net cash
- $382M
- Operating profit, trailing twelve months
- −$102M
- Debt / equity
- 0.00×
- Annualised volatilitytwo years of daily moves
- 104%
- Worst drawdown on file
- −88%
- Below its 52-week high
- −59%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.
Drug Manufacturers - Specialty & Generic
The closest names by size in the same industry